This global biotech stock could soar 398% in the next year, Morgan Stanley says
The company develops regenerative cell medicines for issues such as strokes and traumatic brain injuries.
Source link
The company develops regenerative cell medicines for issues such as strokes and traumatic brain injuries.
Source link